Among active 13F managers last quarter, 3 opened and 1 added, while 1 reduced; the largest holder to move was Armistice Capital, LLC (−65%). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
9 tracked 13F filers disclose a position in IVF as of the latest SEC 13F filings, a combined $568K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Mariner, LLC | 100K | $272K | ▲New +100K sh | Q1 2026 | |
| 2 | Armistice Capital, LLC | 72K | $195K | ▼−65% Reduced · −136K sh | Q1 2026 | |
| 3 | Scientech Research LLC | 32K | $61K | ▲New +32K sh | Q2 2026 | |
| 4 | StoneX Group Inc. | 16K | $30K | ▲New +16K sh | Q2 2026 | |
| 5 | UBS Group AG | 3K | $9K | ▲New +3K sh | Q1 2026 | |
| 6 | SBI Securities Co., Ltd. | 53 | $101 | ▲18× Added · +50 sh | Q2 2026 | |
| 7 | Caitong International Asset Management Co., Ltd | 38 | $72 | ▲New +38 sh | Q2 2026 | |
| 8 | Citigroup Inc | 15 | $41 | ▲15× Added · +14 sh | Q1 2026 | |
| 9 | Danske Bank A/s | 1 | $2 | ▲New +1 sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 3 funds opened a new position in IVF and 1 added to an existing one, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Advanced Micro DevicesAMD | 5 funds | $96.4M |
| Intel CorpINTC | 5 funds | $76.6M |
| Taiwan Semiconductor-SP ADRTSM | 5 funds | $67.3M |
| Corning IncGLW | 5 funds | $52.4M |
| Nebius Group NVNBIS | 5 funds | $42.9M |
| Bloom Energy Corp- ABE | 5 funds | $38.1M |
| Alibaba Group Holding-SP ADRBABA | 5 funds | $33.9M |
| Applied Materials IncAMAT | 5 funds | $28.8M |
| Lam Research CorpLRCX | 5 funds | $19.7M |
| Rocket Lab CorpRKLB | 5 funds | $18.7M |
| Nvidia CorpNVDA | 4 funds | $528.3M |
| Alphabet Inc-CL AGOOGL | 4 funds | $173.4M |
Ranked by how many of IVF's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in IVF.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Dec 3, 2025 | Szot Matthew K | Director | Sell (S) | 4 | $6 |
| Jun 1, 2022 | Messina Rebecca | Director | Buy (P) | 10K | $9K |
| Jun 1, 2022 | Goren Andrea | Chief Financial Officer | Buy (P) | 53K | $50K |
| Jun 1, 2022 | Campbell Michael Jos. | Chief Operating Officer, Director | Buy (P) | 11K | $10K |
| Jun 1, 2022 | Segal Jeffrey | Director | Buy (P) | 9K | $9K |
| Jun 1, 2022 | Szot Matthew K | Director | Buy (P) | 14K | $14K |
| Jun 1, 2022 | Davis Trent D | Director | Buy (P) | 11K | $11K |
| Jun 1, 2022 | Ryan Barbara | Director | Buy (P) | 11K | $10K |
| Jun 1, 2022 | Shum Steve | Chief Executive Officer, Director | Buy (P) | 59K | $56K |
| Jun 1, 2022 | Doody Kevin | Medical Director, Director | Sell (P) | 177K | $168K |
| Oct 5, 2021 | Shum Steve | Chief Executive Officer, Director | Buy (P) | 31K | $100K |
| Oct 5, 2021 | Goren Andrea | Chief Financial Officer | Buy (P) | 31K | $100K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 2 | 1 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
| Class | 13F holders | Value held |
|---|---|---|
| IVFthis pageCOM | 9 funds | $568K |
| 44984F807Stock | 1 funds | $35 |
| 44984F708COMMON STOCK | 1 funds | $0 |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
Connected entities for IVF
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/IVF/capital-change-brief"
Use Arkolith's capital_change_brief for IVF. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for IVF. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.